Target intelligence / Profile preview

Beta-amyloid Peptide Aggregation (Aβ Aggregation)

Target
Aβ Aggregation
Molecular classification
Peptide aggregate, Protein aggregate
01

Overview

Beta-amyloid (Aβ) peptide aggregation refers to the process by which Aβ peptides self-associate into ordered oligomers and fibrillar structures. These aggregates are the principal component of amyloid plaques found in the brains of individuals with Alzheimer’s disease (AD), and their accumulation is a hallmark of this neurodegenerative disorder. Targeting this aggregation is a major therapeutic strategy under investigation for Alzheimer’s disease.

Other names
Amyloid-beta aggregationAbeta aggregationBeta-amyloid oligomerizationAmyloid plaque formation
02

Mechanism of action

Inhibition of nucleation, stabilization of non-toxic conformers/monomers, disruption of existing aggregates/fibrils, modulation of APP processing pathways

03

Biological functions

NeurotoxicitySynaptic dysfunctionInflammationAmyloid plaque formation
04

Disease associations

Alzheimer's diseaseNeurodegenerative disease
05

Safety considerations

Non-selective targeting of Aβ formsInflammation induced by aggregate disruptionOff-target effects of APP processing modulators
06

Biomarkers

Aβ40 levelsAβ42 levelsAmyloid plaque load (imaging)

Beyond the preview

Go deeper on Beta-amyloid Peptide Aggregation (Aβ Aggregation).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Beta-amyloid Peptide Aggregation (Aβ Aggregation).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call